Sonnet Biotherapeutics Holdings Inc (SONN) — Net Asset Quality Index
Sonnet Biotherapeutics Holdings Inc (SONN) has a Net Asset Quality Index of -148.2% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.06 Million minus total liabilities of $5.10 Million yields net assets of $-3.05 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check SONN asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sonnet Biotherapeutics Holdings Inc Net Asset Quality Index Over Time (2007–2025)
This chart shows how Sonnet Biotherapeutics Holdings Inc's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2025, the index stands at -148.2%, representing net assets of $-3.05 Million against total assets of $2.06 Million USD. See working capital position of Sonnet Biotherapeutics Holdings Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Sonnet Biotherapeutics Holdings Inc (2007–2025)
The table below presents the year-by-year Net Asset Quality Index for Sonnet Biotherapeutics Holdings Inc from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Sonnet Biotherapeutics Holdings Inc (SONN) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 72.5% | $10.79 Million | $14.88 Million | $4.10 Million | ▲ +90.0 pp |
| 2024 | -17.5% | $-485.74K | $2.77 Million | $3.26 Million | ▼ -13.4 pp |
| 2023 | -4.2% | $-225.98K | $5.43 Million | $5.66 Million | ▲ +39.4 pp |
| 2022 | -43.5% | $-2.54 Million | $5.83 Million | $8.37 Million | ▼ -120.3 pp |
| 2021 | 76.8% | $22.26 Million | $28.99 Million | $6.73 Million | ▲ +39.0 pp |
| 2020 | 37.8% | $3.02 Million | $7.99 Million | $4.97 Million | ▲ +7195.5 pp |
| 2019 | -7157.7% | $-2.85 Million | $39.75K | $2.89 Million | ▼ -7185.5 pp |
| 2018 | 27.7% | $8.26 Million | $29.79 Million | $21.54 Million | ▼ -10.3 pp |
| 2017 | 38.1% | $11.49 Million | $30.18 Million | $18.69 Million | ▼ -3.6 pp |
| 2016 | 41.7% | $13.96 Million | $33.49 Million | $19.52 Million | ▼ -9.9 pp |
| 2015 | 51.6% | $21.76 Million | $42.21 Million | $20.45 Million | ▲ +9.7 pp |
| 2015 | 41.8% | $14.97 Million | $35.79 Million | $20.82 Million | ▼ -14.1 pp |
| 2013 | 55.9% | $11.24 Million | $20.09 Million | $8.85 Million | ▲ +0.0 pp |
| 2013 | 55.9% | $11.24 Million | $20.09 Million | $8.85 Million | ▲ +26.1 pp |
| 2012 | 29.8% | $1.64 Million | $5.50 Million | $3.86 Million | ▲ +24.0 pp |
| 2011 | 5.8% | $82.42 Million | $1.41 Billion | $1.33 Billion | ▼ -43.6 pp |
| 2009 | 49.4% | $718.02K | $1.45 Million | $735.65K | ▼ -19.8 pp |
| 2008 | 69.2% | $1.54 Million | $2.23 Million | $686.12K | ▼ -21.7 pp |
| 2007 | 90.9% | $3.48 Million | $3.82 Million | $349.27K | — |